Sustime Pharma Limited - Company Profile

Q: Who are the current directors of Sustime Pharma Limited?

The current directors of Sustime Pharma Limited are Shivaji Baburao Patil, Kaushik Kantilal Shah, Sheela Nirmal Bhogilal.

It is a machinery and equipment public limited company based in Mumbai, Maharashtra, India, established in 1992.

1992 Mumbai, Maharashtra, India Active

Last Updated: January 09, 2026

Access Report

About Sustime Pharma Limited

Sustime Pharma Limited, a active public limited company, was established on 25 February 1992 in Mumbai, Maharashtra, India. Engaging in industrial tools & components within the trade sector, it holds CIN: U24230MH1992PLC065589. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.90 Cr.

It upholds a compliant status. Its leadership includes Shivaji Baburao Patil (Director), Kaushik Kantilal Shah (Director), Sheela Nirmal Bhogilal (Director). Past directors included Pradeep Jagjivan Pradhan, Krishnakumar Vasudeo Deorukhkar, Shivaji Baburao Patil. It holds ₹5.00 M open charges and ₹9.68 M settled loans. Its latest AGM occurred on 19 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bharat House 5Th Floorb S Marg Fort, Mumbai, Maharashtra, 400001.

Company Details

CIN/LLPIN
U24230MH1992PLC065589
Registration Number
065589
Incorporation Date
25 February 1992
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹1.90 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 09-01-2026
Paid Up Capital ₹ 1.90 Cr as on 09-01-2026
Company Age 34 Year, 3 Days
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 5.00 M as on 09-01-2026
Satisfied Charges ₹ 9.68 M as on 09-01-2026
Revenue Growth **** -100.00% (FY 2022)
Ebitda **** 100.00% (FY 2022)
Net Worth ****
Total Assets **** % (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Sustime Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sustime Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Shivaji Baburao Patil	Director	21 Feb 2022	Current
Kaushik Kantilal Shah	Director	08 Sep 2003	Current
Sheela Nirmal Bhogilal	Director	25 May 1993	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	09 Oct 2017	Past
Pramod Abcsdd	Director	22 Feb 2013	Past
Pramod Abcsdd	Additional Director	20 Sep 2022	Past
Pramod Abcsdd	Director	21 Feb 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sustime Pharma.

Sustime Pharma Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-100.00%

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

100.00%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sustime Pharma?

In 2022, Sustime Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹5,000,000.00

Satisfied Charges

₹9,675,000.00

Charges Breakdown by Lending Institutions

Maharashtra State Financial Corp. : 0.50 Cr
The North Kanara G.B.B. Co-Op .Bank Ltd. : 0.25 Cr
The North Kanara G.S.B. Co-Op Bank Ltd. : 0.22 Cr

Latest Charge Details

Date	Lender	Amount	Status
17 Aug 1994	The North Kanara G.B.B. Co-Op .Bank Ltd.	₹2.48 M	Satisfied
28 Jun 1994	The North Kanara G.S.B. Co-Op Bank Ltd.	₹2.20 M	Satisfied
01 Mar 1994	Maharashtra State Financial Corp.	₹5.00 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sustime Pharma?

Unlock and access historical data on people associated with Sustime Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sustime Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sustime Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sustime Pharma

Recent Activity within the Organization

Charges

The activity A charge registered on 01 Mar 1994 via Charge ID 90162867 with Maharashtra State Financial Corp. was fully satisfied on 02 Jul 2025. was completed.
02 Jul 2025
Annual General Meeting

Sustime Pharma Limited last Annual general meeting of members was held on 19 Sep 2024 as per latest MCA records. was recorded as a recent event.
19 Sep 2024
Balance Sheet

Progress on Sustime Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
31 Mar 2024
Director Appointment

Progress on Shivaji Baburao Patil was appointed as a Director was appointed as a Director on 21 Feb 2022 & has been associated with this company since 4 years 6 days . was documented.
21 Feb 2022
Charges

A charge registered on 17 Aug 1994 via Charge ID 90166894 with The North Kanara G.B.B. Co-Op .Bank Ltd. was fully satisfied on 05 Feb 2020. was recorded as a recent event.
05 Feb 2020
Charges

The activity A charge registered on 28 Jun 1994 via Charge ID 90162959 with The North Kanara G.S.B. Co-Op Bank Ltd. was fully satisfied on 05 Feb 2020. was completed.
05 Feb 2020

Explore recent activity and updates - View Recent Activity